Search Results
Results found for "Barak LS"
Posts (13)
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Slosky LM, Caron MG, Barak LS. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
. 👉 Learn more about CELT-311 References Booij TH, Price LS, Danen EHJ. 3D Cell-Based Assays for Drug
- Molecular targets of psychedelic-induced plasticity
August 2022 "Psychedelic research across different disciplines and biological levels is growing at a remarkably fast pace. In the prospect of a psychedelic drug becoming again an approved treatment, much of these efforts have been oriented toward exploring the relationship between the actual psychedelic effects and those manifestations of therapeutic interest. Considering the central role of the serotonin 5-HT2A receptor in the distinct effects of psychedelics in human psyche, neuropharmacology sits at the center of this debate and exploratory continuum. Here we discuss some of the most recent findings in human studies and contextualize them considering previous preclinical models studying phenomena related to synaptic plasticity. A special emphasis is placed on knowledge gaps, challenges, and limitations to evaluate the underpinnings of psychedelics' potential antidepressant action." Read more at the source #DrGPCR #GPCR #IndustryNews
Other Pages (1)
- Dr. Caron Tribute Part 2 | Dr. GPCR Ecosystem
Larry Barak (1994) Dr. Kathleen Caron - Co-host- (1970) Dr. Steve Ferguson (1995) Dr.
